Published in Neurology on June 28, 2005
The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology (2013) 1.74
Structural and functional imaging in parkinsonian syndromes. Radiographics (2014) 1.41
MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol (2007) 1.21
Improved DTI registration allows voxel-based analysis that outperforms tract-based spatial statistics. Neuroimage (2014) 1.19
Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials. Parkinsonism Relat Disord (2011) 1.08
Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism. Neuroradiology (2010) 1.03
Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging. Neuroradiology (2012) 0.99
Imaging of corticobasal degeneration syndrome. Neuroradiology (2007) 0.96
3-D analysis of cortical morphometry in differential diagnosis of Parkinson's plus syndromes: mapping frontal lobe cortical atrophy in progressive supranuclear palsy patients. Med Image Comput Comput Assist Interv (2007) 0.95
Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur J Neurol (2013) 0.92
A review of the use of magnetic resonance imaging in Parkinson's disease. Ther Adv Neurol Disord (2014) 0.88
Midbrain atrophy in subcortical ischemic vascular dementia. J Neurol (2009) 0.86
Magnetic resonance imaging in progressive supranuclear palsy. J Neurol (2010) 0.83
Morphometric analysis of subcortical structures in progressive supranuclear palsy: In vivo evidence of neostriatal and mesencephalic atrophy. Psychiatry Res (2011) 0.81
Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome. J Neural Transm (Vienna) (2006) 0.81
Utility of the Midbrain Tegmentum Diameter in the Differential Diagnosis of Progressive Supranuclear Palsy from Idiopathic Parkinson's Disease. J Clin Neurol (2015) 0.81
Midbrain atrophy in vascular Parkinsonism. Eur Neurol (2011) 0.80
Fully automated segmentation of the pons and midbrain using human T1 MR brain images. PLoS One (2014) 0.80
Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy. Neuroradiology (2015) 0.79
Neuroimaging in dementia. Semin Neurol (2008) 0.78
Progressive supranuclear palsy presenting with urinary retention and sleep apnea. Clin Auton Res (2011) 0.78
Major depressive disorder preceding the onset of progressive supranuclear palsy. Psychiatry Investig (2009) 0.77
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? Mov Disord (2017) 0.77
Progression of brain atrophy in PSP and CBS over 6 months and 1 year. Neurology (2016) 0.76
Brain alterations and mini-mental state examination in patients with progressive supranuclear palsy: voxel-based investigations using f-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging. Dement Geriatr Cogn Dis Extra (2011) 0.76
Cerebral peduncle angle: Unreliable in differentiating progressive supranuclear palsy from other neurodegenerative diseases. Parkinsonism Relat Disord (2016) 0.76
Camptocormia and Parkinson's disease: MR imaging. Eur Radiol (2008) 0.76
New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology (2006) 0.76
Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease. Neuroimage Clin (2016) 0.76
The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome. Neuroimage Clin (2014) 0.75
Progressive supranuclear palsy misdiagnosed as Parkinson's disease: a case report and review of literature. Ann Med Health Sci Res (2013) 0.75
Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease. PLoS One (2016) 0.75
MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-parkinsonism. Neurology (2016) 0.75
Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update. Parkinsons Dis (2016) 0.75
Interhemispheric inhibition in different phenotypes of progressive supranuclear palsy. J Neural Transm (Vienna) (2012) 0.75
Midbrain morphology reflects extent of brain damage in Krabbe disease. Neuroradiology (2015) 0.75
Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy. Neuroradiology (2017) 0.75
Parkinsonism in a patient with valosin-containing protein gene mutation showing: a case report. J Neurol (2017) 0.75
Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau. Mayo Clin Proc (2017) 0.75
Magnetic resonance imaging for the diagnosis of Parkinson's disease. J Neural Transm (Vienna) (2017) 0.75
MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson's disease. Neurol Sci (2017) 0.75
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell (1998) 12.66
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett (1997) 11.19
A highly sensitive method to assay FK-506 levels in plasma. Transplant Proc (1987) 8.45
Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. J Biol Chem (1968) 6.28
Purification and properties of bacterial chondroitinases and chondrosulfatases. J Biol Chem (1968) 5.66
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature (1988) 5.60
A 300 kilobase interval genetic map of rice including 883 expressed sequences. Nat Genet (1994) 5.08
Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene (2010) 4.81
Clinical Studies on Behçet's Syndrome. Ann Rheum Dis (1963) 4.61
Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A (1990) 4.40
X-ray diffraction evidence for the extensibility of actin and myosin filaments during muscle contraction. Biophys J (1994) 4.37
Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet (1994) 4.36
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature (1997) 4.27
Amino acid sequence of the human fibronectin receptor. J Cell Biol (1987) 4.08
Behçet disease (Behçet syndrome). Semin Arthritis Rheum (1979) 3.88
Simultaneous observation of individual ATPase and mechanical events by a single myosin molecule during interaction with actin. Cell (1998) 3.79
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J (1994) 3.60
Studies on protein binding of cefazolin and other antibiotics. Jpn J Antibiot (1974) 3.59
Chromospheric alfvenic waves strong enough to power the solar wind. Science (2007) 3.58
Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-beta-lactamase gene blaIMP. Antimicrob Agents Chemother (1998) 3.57
Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet (1994) 3.39
IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology (2010) 3.34
MHC class II molecules are not required for survival of newly generated CD4+ T cells, but affect their long-term life span. Immunity (1996) 3.20
Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry (2007) 3.12
Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet (1996) 3.07
Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol (1992) 3.04
Role of cytosolic phospholipase A2 in allergic response and parturition. Nature (1997) 2.88
Indoleamine 2,3-dioxygenase. Purification and some properties. J Biol Chem (1978) 2.78
Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J (1985) 2.69
Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J Biochem (1995) 2.69
Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2. Nat Immunol (2000) 2.67
cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. Proc Natl Acad Sci U S A (1986) 2.58
Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke (2001) 2.51
Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J (2000) 2.49
Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J (2000) 2.48
The effects of propofol, isoflurane, and sevoflurane on oxygenation and shunt fraction during one-lung ventilation. Anesth Analg (1998) 2.38
Gene cloning of chitinase A1 from Bacillus circulans WL-12 revealed its evolutionary relationship to Serratia chitinase and to the type III homology units of fibronectin. J Biol Chem (1990) 2.38
Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J Biol Chem (1997) 2.38
Phenotypic difference of normal plasma cells from mature myeloma cells. Blood (1993) 2.35
Pattern electrical stimulation of the human retina. Vision Res (1999) 2.35
Control of cell pattern in the developing nervous system: polarizing activity of the floor plate and notochord. Cell (1991) 2.31
A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med (2000) 2.30
Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors. J Med Chem (1996) 2.29
Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol (1994) 2.28
Identification of glutamic acid 204 and aspartic acid 200 in chitinase A1 of Bacillus circulans WL-12 as essential residues for chitinase activity. J Biol Chem (1993) 2.28
Arginine-glycine-aspartic acid adhesion receptors. Methods Enzymol (1987) 2.25
Position of immobilization after dislocation of the glenohumeral joint. A study with use of magnetic resonance imaging. J Bone Joint Surg Am (2001) 2.24
1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun (1981) 2.21
Membrane hyperpolarization inhibits agonist-induced synthesis of inositol 1,4,5-trisphosphate in rabbit mesenteric artery. J Physiol (1992) 2.20
Frequency and stability of chromosomal integration of adenovirus vectors. J Virol (1999) 2.18
The gene for Machado-Joseph disease maps to human chromosome 14q. Nat Genet (1993) 2.18
Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med (1991) 2.17
Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation (1995) 2.15
Effects of trauma and sepsis on soluble L-selectin and cell surface expression of L-selectin and CD11b. J Trauma (1998) 2.15
Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant (2000) 2.15
Subtotal corpectomy versus laminoplasty for multilevel cervical spondylotic myelopathy: a long-term follow-up study over 10 years. Spine (Phila Pa 1976) (2001) 2.14
Impact of single-port cholecystectomy on postoperative pain. Br J Surg (2011) 2.14
The influence of p-nitrophenyl beta-d-xyloside on the synthesis of proteochondroitin sulfate by slices of embryonic chick cartilage. J Biochem (1973) 2.08
Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase. Proc Natl Acad Sci U S A (1991) 2.08
Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J Physiol (2001) 2.08
Enzyme with dual lipoxygenase activities catalyzes leukotriene A4 synthesis from arachidonic acid. Proc Natl Acad Sci U S A (1984) 2.05
Clinical features of a new disease concept, IgG4-related thyroiditis. Scand J Rheumatol (2013) 2.05
Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res (2000) 2.03
Adenylate cyclases in yeast: a comparison of the genes from Schizosaccharomyces pombe and Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1989) 2.01
Keratosis follicularis squamosa (Dohi): a follicular keratotic disorder well known in Japan. Br J Dermatol (2001) 2.01
Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol Psychiatry (2004) 2.00
Decline in sex ratio at birth after Kobe earthquake. Hum Reprod (1998) 1.98
Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med (1998) 1.98
Pulmonary artery disease in Takayasu's arteritis: angiographic findings. AJR Am J Roentgenol (1992) 1.96
Laparoscopic removal of a large gastric trichobezoar. J Pediatr Surg (1998) 1.96
Eyelid reconstruction using a hard palate mucoperiosteal graft combined with a V-Y subcutaneously pedicled flap. Br J Plast Surg (2001) 1.96
Early gastric cancer. Endoscopic diagnosis of depth of invasion. Dig Dis Sci (1990) 1.94
Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke (2000) 1.94
Adherence of Bordetella bronchiseptica to swine nasal epithelial cells and its possible role in virulence. Res Vet Sci (1979) 1.93
Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet (1998) 1.91
The roles of the C-terminal domain and type III domains of chitinase A1 from Bacillus circulans WL-12 in chitin degradation. J Bacteriol (1994) 1.91
Possible relationship of a 36-megadalton Salmonella enteritidis plasmid to virulence in mice. Infect Immun (1985) 1.91
Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke (1995) 1.90
Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells. Endocrinology (1991) 1.90
In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus. Antimicrob Agents Chemother (1989) 1.90
Tremorgenic toxins from Aspergillus fumigatus Fres. Chem Pharm Bull (Tokyo) (1971) 1.88
The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun (1990) 1.88
Structural analysis of chick-embryo cartilage proteoglycan by selective degradation with chondroitin lyases (chondroitinases) and endo-beta-D-galactosidase (keratanase). Biochem J (1980) 1.86
Formation of three types of disulfated disaccharides from chondroitin sulfates by chondroitinase digestion. J Biol Chem (1968) 1.86
Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells. J Antibiot (Tokyo) (1991) 1.86
Multitissue circadian expression of rat period homolog (rPer2) mRNA is governed by the mammalian circadian clock, the suprachiasmatic nucleus in the brain. J Biol Chem (1998) 1.86
Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue. J Biol Chem (1998) 1.86
Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest (1993) 1.85
Suppression of DNA replication via Mos function during meiotic divisions in Xenopus oocytes. EMBO J (1994) 1.84
Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science (2001) 1.84
N-cadherin redistribution during synaptogenesis in hippocampal neurons. J Neurosci (1998) 1.84
Immunological studies on Behçet's syndrome. Ann Rheum Dis (1965) 1.82
The virR/virS locus regulates the transcription of genes encoding extracellular toxin production in Clostridium perfringens. J Bacteriol (1996) 1.82
Partial purification and characterization of UDPG:t-cinnamate glucosyltransferase in the root of sweet potato, Ipomoea batatas Lam. J Biochem (1984) 1.82
Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes (2001) 1.82
Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res (2000) 1.82
Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. J Natl Cancer Inst (1997) 1.81
Vitronectin--a major cell attachment-promoting protein in fetal bovine serum. Exp Cell Res (1985) 1.81